A life behind life science

Noreen O'Neill, who died of melanoma in July, 2000. Credit: Courtesy of the O'Neill family" />Noreen O'Neill, who died of melanoma in July, 2000. Credit: Courtesy of the O'Neill family Meenhard Herlyn studied melanoma for 20 years before he ever met a single patient with the disease. He has published more than 380 papers on melanoma and other cancers, in which he discovered monoclonal antibod

Written byBob Grant
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Meenhard Herlyn studied melanoma for 20 years before he ever met a single patient with the disease. He has published more than 380 papers on melanoma and other cancers, in which he discovered monoclonal antibodies to tumor cells that are still used to diagnose some types of cancer, characterized stages in melanoma's progression, and identified genes that play key roles in that progression.

Then, on a spring morning in 1998, Herlyn met Noreen O'Neill and her sister Kate in a conference room at the Wistar Institute in Philadelphia. Noreen had been diagnosed with melanoma three years earlier, and she and the scientist hit it off right away. "In the first fifteen minutes there was no question that they would be working together," Kate remembers. Herlyn admits that he was instantly taken with Noreen. "She was a very beautiful person, and very radiant, and very outgoing, and very personable," he says.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies